Search Results
Dr. Clifford Hudis on Why Resistance to HER-2 Therapies Needs to be Further Researched
Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer
Dr. Clifford A. Hudis on In-Breast Response Rates in Triple-Negative Breast Cancer
Dr. Clifford Hudis Highlights Two Abstracts From the 2013 ASCO Annual Meeting
Clifford A. Hudis, MD: Immunotherapy Highlights as ASCO 2013
Dr. Clifford Hudis on link between post-menopausal breast cancer & inflammation, dietary fats
Clifford A. Hudis, MD: A History of Anti-Angiogenesis
Clifford A. Hudis, MD: What's New With Chemotherapy Trials?
Dr. Hudis Discusses the CALGB 40601 Study in Breast Cancer
Clifford A. Hudis, MD: T-DM1 EMILIA Trial for HER-2 Positive Advanced Breast Cancer
Dr. Hudis on the Challenges of TNBC
Dr. Clifford Hudis Remarks and Q&A Intro